Quantum Biopharma (QNTM) Debt Ratio (2019 - 2026)

Quantum Biopharma has disclosed Debt Ratio across 8 years of filings, most recently posting 0.06 for Q2 2026.

• In Q2 2026, Debt Ratio fell 54.71% year-over-year to 0.06; the TTM figure through Jun 2026 stood at 0.06 (down 54.71% YoY), while the FY2025 annual figure was 0.16, up 252.67% from the prior year.
• Debt Ratio came in at 0.06 for Q2 2026 at Quantum Biopharma, up from 0.05 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.17 in Q3 2025 to a low of 0.01 in Q1 2022.
• Average Debt Ratio over 5 years is 0.05, with a median of 0.02 recorded in 2023.
• Year-over-year, Debt Ratio surged 975.88% in 2025 and tumbled 54.71% in 2026.
• Over 5 years, Debt Ratio stood at 0.01 in 2022, then surged by 119.81% to 0.02 in 2023, then surged by 161.91% to 0.05 in 2024, then surged by 252.67% to 0.16 in 2025, then slumped by 60.71% to 0.06 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.06 in Q2 2026, 0.05 in Q1 2026, and 0.16 in Q4 2025.